Since launch in mid-2Q15, Arthrosurface’s motion preserving WristMotion™ hemiarthroplasty implant has been used in >100 procedures in the U.S.
WristMotion features an anatomic implant to resurface arthritic capitate bone. The implant creates a new articulating surface and is designed to preserve more bone than other implants. Follow-up on early patients has shown the implants to be stable, yielding a pain-free return to activity.
The wrist hemiarthroplasty system received FDA 510(k) clearance to market in 4Q14.
Since launch in mid-2Q15, Arthrosurface's motion preserving WristMotion™ hemiarthroplasty implant has been used in >100 procedures in the U.S.
WristMotion features an anatomic implant to resurface arthritic capitate bone. The implant creates a new articulating surface and is designed to preserve more bone than other implants. Follow-up on...
Since launch in mid-2Q15, Arthrosurface’s motion preserving WristMotion™ hemiarthroplasty implant has been used in >100 procedures in the U.S.
WristMotion features an anatomic implant to resurface arthritic capitate bone. The implant creates a new articulating surface and is designed to preserve more bone than other implants. Follow-up on early patients has shown the implants to be stable, yielding a pain-free return to activity.
The wrist hemiarthroplasty system received FDA 510(k) clearance to market in 4Q14.
Copy to clipboard 
